by Elena Iemma | May 28, 2025 | Blog, Uncategorized
The new CSO starts on June 1st! Drumroll please…. We are pleased to welcome Dr. Vibha Jawa as the new Chief Scientific Officer at EpiVax! Please see this link for more information about this latest update to EpiVax 2.0. (I will be around to help transition)....
by Elena Iemma | May 28, 2025 | News
EpiVax Appoints Dr. Vibha Jawa to Lead Scientific Strategy as CSO PROVIDENCE, R.I., May 28, 2025 /PRNewswire/ — EpiVax, Inc., a leader in preclinical immunogenicity assessment for biologic therapeutics and vaccines, is pleased to announce the...
by Elena Iemma | May 19, 2025 | Blog
FDA Roadmap to Reducing Animal Testing:A Step Toward Smarter Tools for in silico Immunogenicity Risk Assessment The FDA’s new Roadmap to Reducing Animal Testing in Preclinical Safety Studies lays out a phased plan to move away from animal models and toward...
by Elena Iemma | Apr 30, 2025 | Events
The 11th annual Amsterdam Immunogenicity & Tolerance Seminar November 7, 2025 | 9:30 am – 5:00 pm | The Hilton Apollolaan Hotel Register About the Amsterdam Immunogenicity & Tolerance Seminar:Now in its 11th year, The Amsterdam Immunogenicity &...
by Elena Iemma | Apr 30, 2025 | Events
The 17th annual Westin Immunogenicity Seminar Thursday, September 25, 2025 | 9:00 am – 6:00 pm | The Westin Hotel, Meguro, Tokyo REGISTER Join us for the 17th Annual Westin Immunogenicity Seminar, a free event that brings together leaders in immunology,...
